Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Breast Neoplasms 4Esophageal Squamous Cell Carcinoma 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Locally Advanced Gastric Cancer 2Colorectal Neoplasms 2Cervical Cancer Metastatic 2Triple Negative Breast Neoplasms 1Sarcoma 1Rectal Neoplasms 1Rectal Cancer Patients 1Rare Tumour 1Non-squamous Non-small Cell Lung Cancer 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Laryngeal Neoplasms 1Esophageal Squamour Cell Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Biliary Tract Neoplasms 1Advanced Triple Negative Breast Cancer 1Advanced Pancreatic Cancer 1

Interventions

Capecitabine 13Oxaliplatin 10Radiotherapy 8Surgical Procedures, Operative 6Drug Therapy 5tislelizumab 4Irinotecan 4sintilimab 3Neoadjuvant Therapy 3Immunotherapy 3Fluorouracil 3Endoscopic Mucosal Resection 3Bevacizumab 3spartalizumab 2raltitrexed 2XELOX 2Trinitrotoluene 2Radiation 2Immune Checkpoint Inhibitors 2Folfox protocol 2Cetuximab 2toripalimab 1sperm releasing substance 1saxagliptin 1s-formylglutathione hydrolase 1envafolimab 1disitamab vedotin 1cemiplimab 1camrelizumab 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Rectal Neoplasms × camrelizumab × Clear all
NCT06304545 2024-03-12

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Harbin Medical University

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡